GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes

Medical Xpress

GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure.

These risks are significantly exacerbated if a type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, Ph.D., research assistant professor in the Department of Pharmacy Practice in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. ...

전문 보기

GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Why Facebook, video calls and artificial intelligence matter for age-friendly communities

Fear-learning circuit shows how stress disrupts brain's ability to suppress trauma

Superworms could be the future of skeleton cleaning

Medical Xpress의 다른 기사

Diets that lower inflammation might cut dementia risk, study indicates

Psychedelics not yet ready for clinical use in ADHD treatment, study finds

Whole goat milk formula can reduce incidence of atopic dermatitis in infants